We have a plan. Thank goodness. Matt and I went down to U of C today and, after waiting for far too long, met with Dr. J. He informed us that Matt's light chains have not gone down as much as they would have liked and because of that, they don't believe transplant is the best option. The main reason for this is that the drug they give Matt to wipe his immune system is something called Malphalan, and it's in the same category as the Cytoxin he just received. Meaning there's a high possibility that it wouldn't work as well as they need it to prior to transplant. I also learned today that both of those drugs are in the same class as VDPACE, which is the infusion Matt received before our initial plan of a donor transplant in 2021. Which, of course, didn't work then either. So I think it's safe to say, that category of drugs is essentially useless to Matt. So, we pivot. The new course of action is to do a carT called ciltacel. This ...